Gustave Roussy Cancer Campus
ESMO Fellowship Host Institute
|Contact person||Dr Mahasti Saghatchian, Mr Arnaud Forest|
114 rue Edouard Vaillant
|Contact||Tel: +33 (0)1 42 11 61 59 / +33 (0)1 42 11 66 04 - Mahasti(dot)SAGHATCHIAN(at)igr(dot)fr|
|Web||Gustave Roussy Cancer Campus Grand Paris|
Translational Research Fellowship
Clinical Research Fellowship
The Gustave Roussy Cancer Campus hosts fellows in the following areas:
- Early Trials in Hematology
- Early trials
- Genetic Unit
- Ambulatory Department
- Thyroid surgery unit
- Thoracic Oncology
- Biostatistics department
- Breast Cancer
- Gynecology / Oncology Unit
- Dermatology Service
Training Experience Required
The fellow needs to have at least one year of clinical experience in oncology. For a translational research fellow documented lab experience is needed.
The Institute Gustave-Roussy (IGR), the leading European Cancer Centre, assembles on the same site 2,500 men and women whose missions are to treat patients suffering from cancer, conduct research and develop new therapies, and to pass on knowledge and know-how to the medical and scientific communities in France and world-wide.
The first of the IGR's major missions is to treat cancer patients, including diagnosis, treatment and complementary care. This global approach to patients and their families is made possible by the expertise, human skill and material resources appropriate to oncology.
Institut Gustave-Roussy pioneered the multidisciplinary approach to the treatment of cancer. It is an undisputed expert in all the conceptual and technical fields related to cancer. IGR's activity is centred on rapidly transforming progress in basic research into clinical applications for the benefit of patients
Treatment: In the 400-bed hospital with its 124 statutory physicians, annually over 11,000 new patients are recruited, 130,000 patients attend its clinics and 42,000 patients receive treatment.
Research: Research is conducted by 400 research scientists under the oversight of a scientific council, a therapeutic trials commission and a clinical research committee.
Teaching: Over 5,000 hours of instruction are taught in its School of Oncology in collaboration with the University of Paris. Each of these three missions is founded on principles that are the guiding force behind IGR's actions daily:
- The excellence principle, through which efforts are united to establish quality standards in oncology
- The innovation principle, that is urgently needed for many cancers that are still incurable
- The evaluation principle, without which it is impossible to advance in a rigorous and methodical manner along the path to new therapies.
Contact Person: Mr Arnauld Forest, arnauld.FOREST@igr.fr